Filing Details

Accession Number:
0001209191-24-002881
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-06 08:27:19
Reporting Period:
2024-02-05
Accepted Time:
2024-02-06 08:27:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1633932 Essa Pharma Inc. EPIX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1826322 Peter Virsik C/O Essa Pharma Inc.
999 West Broadway, Suite 720
Vancouver A1 V5Z 1K5
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2024-02-05 694 $9.25 13,328 No 4 S Direct
Common Shares Acquisiton 2024-02-05 500 $3.23 13,828 No 4 M Direct
Common Shares Disposition 2024-02-05 500 $10.04 13,328 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Options Disposition 2024-02-05 500 $0.00 500 $3.23
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
967,782 2023-10-07 2029-10-07 No 4 M Direct
Footnotes
  1. Reflects a transaction effected pursuant to Mr. Virsik's 10b5-1 trading plan. The Rule 10b5-1 trading plan was entered into on August 31, 2023.
  2. The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.